These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 5982986)

  • 1. [Recent studies on the action mechanism of some central nervous system analgesics. Acetylsalicylic acid, imipramine, iminostilbene].
    Charpentier J
    Psychopharmacologia; 1966; 10(2):126-47. PubMed ID: 5982986
    [No Abstract]   [Full Text] [Related]  

  • 2. Possible peripheral adrenergic and cholinergic mechanisms in pseudoconditioning.
    Izquierdo I
    Psychopharmacologia; 1974 Feb; 35(3):189-93. PubMed ID: 4829321
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacology of a potential anti-Parkinson agent: tigloidine.
    Sanghvi I; Bindler E; Gershon S
    Eur J Pharmacol; 1968 Oct; 4(3):246-53. PubMed ID: 5723419
    [No Abstract]   [Full Text] [Related]  

  • 4. The pharmacology of 4H-3-methylcarboxyamide-1,3-benzoxazine-2-one (F.I. 6654), a compound acting on the central nervous system.
    Suchowsky GK; Pegrassi L
    Arzneimittelforschung; 1969 Apr; 19(4):643-8. PubMed ID: 4977576
    [No Abstract]   [Full Text] [Related]  

  • 5. Anticholinergic potentiation of amphetamine: reinforcement schedule effects.
    Ray OS; Bivens LW
    Arch Int Pharmacodyn Ther; 1968 Apr; 172(2):414-20. PubMed ID: 5684252
    [No Abstract]   [Full Text] [Related]  

  • 6. [Modification of central mechanisms of action by anticholinergics].
    Haas H; Jantos W
    Arzneimittelforschung; 1969 Jan; 19(1):54-62. PubMed ID: 5819363
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of physostigmine and atropine on some behavioral and electrophysiological functions in rats.
    Bures J
    Prog Brain Res; 1968; 28():61-72. PubMed ID: 5699592
    [No Abstract]   [Full Text] [Related]  

  • 8. On the mechanism of potentiation of amphetamine induced stereotype behaviour by imipramine.
    Kulkarni SK; Dandiya PC
    Psychopharmacologia; 1972; 27(4):367-72. PubMed ID: 4265208
    [No Abstract]   [Full Text] [Related]  

  • 9. Synergism by atropine of central stimulant properties of phenylpropanolamine.
    Davis WM; Pinkerton JT
    Toxicol Appl Pharmacol; 1972 May; 22(1):138-45. PubMed ID: 5034981
    [No Abstract]   [Full Text] [Related]  

  • 10. A comparison of antagonists of physostigmine-induced suppression of behavior.
    Vaillant GE
    J Pharmacol Exp Ther; 1967 Sep; 157(3):636-48. PubMed ID: 4963332
    [No Abstract]   [Full Text] [Related]  

  • 11. [DO NEUROTROPIC FLUORESCENT AGENTS ACT UPON THE CENTRAL NERVOUS SYSTEM?].
    FOUSSARD-BLANPIN O; BRETAUDEAU J
    C R Seances Soc Biol Fil; 1964; 158():1931-4. PubMed ID: 14262542
    [No Abstract]   [Full Text] [Related]  

  • 12. Cholinergic and anticholinergic influences on amphetamine-induced stereotyped behavior.
    Klawans HL; Rubovits R; Patel BC; Weiner WJ
    J Neurol Sci; 1972 Nov; 17(3):303-8. PubMed ID: 4653965
    [No Abstract]   [Full Text] [Related]  

  • 13. Central effects of anticholergic drugs measured by the apomorphine gnawing test in mice.
    Scheel-Krüger J
    Acta Pharmacol Toxicol (Copenh); 1970; 28(1):1-16. PubMed ID: 5467751
    [No Abstract]   [Full Text] [Related]  

  • 14. Central nervous actions and screening methods of antidepressants.
    Ogura C; Kimishima K
    Folia Psychiatr Neurol Jpn; 1972; 26(4):291-317. PubMed ID: 4144774
    [No Abstract]   [Full Text] [Related]  

  • 15. The effects of amphetamine, imipramine and ICI 58,834 (Vivalan), a potential antidepressant, on unconditioned behaviour in rats.
    Cox T; Tye N
    Psychopharmacologia; 1975; 40(4):297-304. PubMed ID: 1144643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropharmacological comparison of cyclazocine and imipramine.
    Drew WG; White RP
    Pharmacology; 1973; 9(2):65-73. PubMed ID: 4713006
    [No Abstract]   [Full Text] [Related]  

  • 17. Quantification of slow-wave EEG induced by atropine: effects of physostigmine, amphetamine and haloperidol.
    Santucci V; Glatt A; Demieville H; Olpe HR
    Eur J Pharmacol; 1981 Jul; 73(2-3):113-22. PubMed ID: 7308289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioral facilitation: the interaction of imipramine and desipra- mine with amphetamine, alpha-pipradrol, methylphenidate, and thozalinone.
    Berstein BM; Latimer CN
    Psychopharmacologia; 1968; 12(4):338-45. PubMed ID: 4385109
    [No Abstract]   [Full Text] [Related]  

  • 19. A potential screening test for minor tranquilizing drug action.
    Morrison CF
    Br J Pharmacol; 1970 Feb; 38(2):460P. PubMed ID: 5417886
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of atropine and related drugs on the EEG and behaviour.
    Bradley PB
    Prog Brain Res; 1968; 28():3-13. PubMed ID: 4301741
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.